Cardica, Inc. Recalls 55 C-Port Devices
The devices are used by surgeons to perform coronary artery bypass surgery. The company reported the voluntary recall to the Securities and Exchange Commission in a Jan. 12 filing. The company said the Food and Drug Administration has been notified.
The defect is in a single component, though the company said it believes the defect does not pose a hazard to patients. Replacement devices are being provided.
The recall will hurt the company's fiscal results in the fourth quarter and first quarter, according to the SEC filing. Cardica did not provide an estimate.
Shares of Redwood, Calif.-based Cardica fell 49 cents, or 10 percent, to $4.40 on the Nasdaq in morning trading. The stock has traded between $3.84 and $10.59 over the last 52 weeks.
Copyright 2006 Associated Press. All rights reserved. This material may not be published broadcast, rewritten, or redistributed